Cargando…

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole

Mucormycosis is a severe opportunistic fungal infection caused by Mucorales. The majority of the affected patients have a history of immunosuppression, with a reported incidence of 4–19% in the immunocompetent. Early recognition and diagnosis, combined with surgical debridement and appropriate antif...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilharco, Marta, Pereira, Carla Maravilha, Moreira, Laura, Proença, Ana Luísa, do Carmo Fevereiro, Maria, Lampreia, Fátima, Oliveira, Miguel Lopes, Rola, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700484/
https://www.ncbi.nlm.nih.gov/pubmed/31453100
http://dx.doi.org/10.1016/j.idcr.2019.e00591
_version_ 1783444884079771648
author Ilharco, Marta
Pereira, Carla Maravilha
Moreira, Laura
Proença, Ana Luísa
do Carmo Fevereiro, Maria
Lampreia, Fátima
Oliveira, Miguel Lopes
Rola, José
author_facet Ilharco, Marta
Pereira, Carla Maravilha
Moreira, Laura
Proença, Ana Luísa
do Carmo Fevereiro, Maria
Lampreia, Fátima
Oliveira, Miguel Lopes
Rola, José
author_sort Ilharco, Marta
collection PubMed
description Mucormycosis is a severe opportunistic fungal infection caused by Mucorales. The majority of the affected patients have a history of immunosuppression, with a reported incidence of 4–19% in the immunocompetent. Early recognition and diagnosis, combined with surgical debridement and appropriate antifungal therapy are essential to achieve a cure. In this article we report the case of a 61-year-old immunocompetent male who complained with pain in his right eye. After being first diagnosed with conjunctivitis and treated accordingly, he eventually needed surgical debridement and the biopsy showed the presence of fungi of the class Zygomycetes. He was submitted to intravenous therapy with Liposomal Amphotericin B (LAmB) and Posaconazole for several days, which was then changed to Isavuconazole due to bicytopenia. He also received treatment with hyperbaric oxygen, achieving altogether good results. He was discharged after eight months, still on oral Isavuconazole 200mg/day and re-evaluated after three and six months, showing no evidence of progression of the infection.
format Online
Article
Text
id pubmed-6700484
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67004842019-08-26 Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole Ilharco, Marta Pereira, Carla Maravilha Moreira, Laura Proença, Ana Luísa do Carmo Fevereiro, Maria Lampreia, Fátima Oliveira, Miguel Lopes Rola, José IDCases Article Mucormycosis is a severe opportunistic fungal infection caused by Mucorales. The majority of the affected patients have a history of immunosuppression, with a reported incidence of 4–19% in the immunocompetent. Early recognition and diagnosis, combined with surgical debridement and appropriate antifungal therapy are essential to achieve a cure. In this article we report the case of a 61-year-old immunocompetent male who complained with pain in his right eye. After being first diagnosed with conjunctivitis and treated accordingly, he eventually needed surgical debridement and the biopsy showed the presence of fungi of the class Zygomycetes. He was submitted to intravenous therapy with Liposomal Amphotericin B (LAmB) and Posaconazole for several days, which was then changed to Isavuconazole due to bicytopenia. He also received treatment with hyperbaric oxygen, achieving altogether good results. He was discharged after eight months, still on oral Isavuconazole 200mg/day and re-evaluated after three and six months, showing no evidence of progression of the infection. Elsevier 2019-07-09 /pmc/articles/PMC6700484/ /pubmed/31453100 http://dx.doi.org/10.1016/j.idcr.2019.e00591 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ilharco, Marta
Pereira, Carla Maravilha
Moreira, Laura
Proença, Ana Luísa
do Carmo Fevereiro, Maria
Lampreia, Fátima
Oliveira, Miguel Lopes
Rola, José
Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
title Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
title_full Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
title_fullStr Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
title_full_unstemmed Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
title_short Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
title_sort rhinoorbital mucormycosis in the immunocompetent: experience with isavuconazole
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700484/
https://www.ncbi.nlm.nih.gov/pubmed/31453100
http://dx.doi.org/10.1016/j.idcr.2019.e00591
work_keys_str_mv AT ilharcomarta rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT pereiracarlamaravilha rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT moreiralaura rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT proencaanaluisa rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT docarmofevereiromaria rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT lampreiafatima rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT oliveiramiguellopes rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole
AT rolajose rhinoorbitalmucormycosisintheimmunocompetentexperiencewithisavuconazole